Compounds derived from quinolinas replaced； Pharmaceutical formulation containing them； and their use for the treatment of a disease that can be treated through inhibition of Syk Enzyme, such as allergic rhinitis, Asthma, bronchitis, COPD, lupus, multiple sclerosis, osteopo Rosis, osteopenia and arteriosclerosis.
DAHMANN GEORG,KLICIC JASNA,HOFFMANN MATTHIAS,BISCHOFF DANIEL,SCHAENZLE GERHARD,WOLLIN STEFAN LUDWIG MICHAEL,CONVERS-REIGNIER SERGE GASTON,EAST STEPHEN PETER,MCCARTHY CLIVE,SCOTT JOHN,MARLIN FREDERIC
申请号：
CL2014000113
公开号：
CL2014000113A1
申请日:
2014.01.15
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
Disclosed are substituted quinolines of formula 1 wherein R1 and R2 are defined herein, the processing of making and using the same.COMPUESTOS DERIVADOS DE QUINOLINAS SUSTITUIDAS； FORMULACION FARMACEUTICA QUE LOS CONTIENE； Y SU USO PARA EL TRATAMIENTO DE UNA ENFERMEDAD QUE SE PUEDE TRATAR MEDIANTE LA INHIBICION DE LA ENZIMA SYK, TALES COMO RINITIS ALERGICA, ASMA, EPOC, BRONQUITIS, LUPUS ERITEMATOSO, ESCLEROSIS MULTIPLE, OSTEOPOROSIS, OSTEOPENIA Y ARTERIOESCLEROSIS, ENTRE OTRAS.
